Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.
Frequently asked questions
What sector does Evoke Pharma Inc (EVOK) operate in?
Evoke Pharma Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Evoke Pharma Inc (EVOK) current stock price?
As of the latest data, Evoke Pharma Inc stock price is $28.10, with a previous close of $28.10.
What is Evoke Pharma Inc (EVOK) current market capitalization?
Evoke Pharma Inc market cap is approximately 48.40 million.
What is Evoke Pharma Inc (EVOK) Earnings Per Share (EPS)?
The trailing EPS is -$1.38, and the forward EPS is $0.68.
Does Evoke Pharma Inc (EVOK) pay dividends?
No. Evoke Pharma Inc does not pay a dividend.
What is Evoke Pharma Inc (EVOK) beta (volatility) score?
Evoke Pharma Inc has a beta of -0.136, indicating lower volatility than the overall market.
